TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable

Molecular Endocrinology

Volumn 25, Issue 4, 2011, Pages 611-620

  Davis, Jennifer S ^a   Nastiuk, Kent L ^a,b   Krolewski, John J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FAS LIGAND; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION;

ANDROGENS; ANIMALS; APOPTOSIS; CASTRATION; EPITHELIAL CELLS; FAS LIGAND PROTEIN; IMMUNOBLOTTING; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; PROSTATE; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROMAL CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

MUS; RATTUS;

EID: 79953741278     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0312     Document Type: Article

References (45)

1. Denmeade SR, Isaacs JT 2002 A history of prostate cancer treatment. Nat Rev Cancer 2:389-396
2. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS 2006 Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 166:465-471
3. Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF 2009 Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol 27:3452-3458
4. Higano CS 2008 Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know? Nat Clin Pract Urol 5:24-34
5. Shah NL, Sanda M 2004 Health-related quality of life in treatment for prostate cancer: looking beyond survival. Support Cancer Ther 1:230-236
6. Roy-Burman P, Tindall DJ, Robins DM, Greenberg NM, Hendrix MJ, Mohla S, Getzenberg RH, Isaacs JT, Pienta KJ 2005 Androgens and prostate cancer: are the descriptors valid? Cancer Biol Ther 4:4-5
7. Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R 1999 An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ 6:48-54
8. Bruckheimer EM, Cho S, Brisbay S, Johnson DJ, Gingrich JR, Greenberg N, McDonnell TJ 2000 The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo. Oncogene 19: 2404-2412
9. Banerjee PP, Banerjee S, Brown TR 2002 Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology 143:1825-1832
10. Kyprianou N, Isaacs JT 1989 Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515-1522
11. Martikainen P, Kyprianou N, Isaacs JT 1990 Effect of transforming growth factor-β1 on proliferation and death of rat prostate cells. Endocrinology 127:2963-2968
12. Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim IY, Lee C 1997 Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1. Prostate 33:64-71
13. Hedlund TE, Duke RC, Schleicher MS, Miller GJ 1998 Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36:92-101
14. Nesterov A, Ivashchenko Y, Kraft AS 2002 Tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21:1135-1140
15. Chopra DP, Menard RE, Januszewski J, Mattingly RR 2004 TNF-β-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 203:145-154
16. Martin DA, Siegel RM, Zheng L, Lenardo MJ 1998 Membrane oligomerization and cleavage activates the caspase-8 (FLICE/ MACHα1) death signal. J Biol Chem 273:4345-4349
17. Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME, Yang X 2002 c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 21:3704-3714
18. Nastiuk KL, Kim JW, Mann M, Krolewski JJ 2003 Androgen regulation of FLICE-like inhibitory protein gene expression in the rat prostate. J Cell Physiol 196:386-393
19. Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ 2008 FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene 27:4422-4433
20. Suzuki A, Matsuzawa A, Iguchi T 1996 Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13:31-37
21. de la Taille A, Chen MW, Shabsigh A, Bagiella E, Kiss A, Buttyan R 1999 Fas antigen/CD-95 upegulation and activation during castration-induced regression of the rat ventral prostate gland. Prostate 40:89-96
22. Sugihara A, Yamada N, Tsujimura T, Iwasaki T, Yamashita K, Takagi Y, Tsuji M, Terada N 2001 Castration induces apoptosis in the male accessory sex organs of Fas- deficient lpr and Fas liganddeficient gld mutant mice. In Vivo 15:385-390
23. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT 1993 Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 90:8910-8914
24. Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ 2007 In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol 7:12
25. Kim Y, Suh N, Sporn M, Reed JC 2002 An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem 277:22320-22329
26. Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK 2001 Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 20:6073-6083
27. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G 1996 Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184: 1397-1411
28. Micheau O, Tschopp J 2003 Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190
29. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Krönke M, Mak TW 1993 Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467
30. Grounds MD, Davies M, Torrisi J, Shavlakadze T, White J, Hodgetts S 2005 Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res 320:509-515
31. Glamoclija V, Vilović K, Saraga-Babić M, Baranović A, Sapunar D 2005 Apoptosis and active caspase-3 expression in human granulosa cells. Fertil Steril 83:426-431
32. Mosselmans R, Hepburn A, Dumont JE, Fiers W, Galand P 1988 Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J Immunol 141:3096-3100
33. Echtenacher B, Urbaschek R, Weigl K, Freudenberg MA, Männel DN 2003 Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiology 208:381-389
34. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY, Goeddel DV 1991 Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834
35. Kulik G, Carson JP, Vomastek T, Overman K, Gooch BD, Srinivasula S, Alnemri E, Nunez G, Weber MJ 2001 Tumor necrosis factor α induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells. Cancer Res 61:2713-2719
36. Katdare M, Efimova EV, Labay E, Khodarev NN, Darga TE, Garofalo M, Nakamura S, Kufe DW, Posner MC, Weichselbaum RR 2007 Diverse TNFα-induced death pathways are enhanced by inhibition of NF-κB. Int J Oncol 31:1519-1528
37. Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS, Rueda BR 2008 Acid sphingomyelinase involvement in tumor necrosis factor α-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci USA 105: 7670-7675
38. Korzekwa A, Murakami S, Woclawek-Potocka I, Bah MM, Okuda K, Skarzynski DJ 2008 The influence of tumor necrosis factor α (TNF) on the secretory function of bovine corpus luteum: TNF and its receptors expression during the estrous cycle. Reprod Biol 8:245-262
39. Siegel PM, Massagué J 2003 Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 3:807-821
40. Gao S, Lee P, Wang H, Gerald W, Adler M, Zhang L, Wang YF, Wang Z 2005 The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol 19:1792-1802
41. Raclaw KA, Heemers HV, Kidd EM, Dehm SM, Tindall DJ 2008 Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis. Prostate 68:1696-1706
42. Nastiuk KL, Yoo K, Lo K, Su K, Yeung P, Kutaka J, Danielpour D, Krolewski JJ 2008 FLICE-like inhibitory protein blocks transforming growth factor β 1-induced caspase activation and apoptosis in prostate epithelial cells. Mol Cancer Res 6:231-242
43. Yoo KS, Nastiuk KL, Krolewski JJ 2009 Transforming growth factor β1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells. Int J Cancer 124:834-842
44. Ohlson N, Wikström P, Stattin P, Bergh A 2005 Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment. Prostate 62:307-315
45. Brodoefel H, Burgstahler C, Sabir A, Yam CS, Khosa F, Claussen CD, Clouse ME 2009 Coronary plaque quantification by voxel analysis: dual-source MDCT angiography versus intravascular sonography. AJR Am J Roentgenol 192:W84-W89